Alzheimer ’s Drug Aduhelm Went From Being Hailed A ‘Game Changer’ To A Dud
Biogen announced it will discontinue marketing the Alzheimer ’s drug Aduhelm. This ends the tortuous saga of a once-promising treatment for the memory-robbing disease.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Joshua Cohen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Editors' Pick editors-pick business pharma & standard Source Type: news